Amoxicillin: Indications, Dosing, Contraindications, and Monitoring
Primary Indications
Amoxicillin is indicated for upper respiratory tract infections (ear, nose, throat), genitourinary tract infections, skin and skin structure infections, lower respiratory tract infections, and in adults specifically for H. pylori infection with duodenal ulcer disease 1.
For community-acquired pneumonia (CAP), amoxicillin serves as the first-choice antibiotic for mild-to-moderate disease in both children and adults 2. The evidence strongly supports amoxicillin over alternatives like sulfamethoxazole-trimethoprim, which shows significantly higher failure rates (RR 1.79) 2.
Dosing Regimens
Adults
- Standard dosing: 750-1750 mg/day divided every 8-12 hours 1
- H. pylori triple therapy: 1 gram twice daily (every 12 hours) with 500 mg clarithromycin and 30 mg lansoprazole for 14 days 1
- H. pylori dual therapy: 1 gram three times daily (every 8 hours) with 30 mg lansoprazole for 14 days 1
Pediatric Patients
For children over 3 months: 20-45 mg/kg/day divided every 8-12 hours 1. However, current WHO guidance recommends higher-dose amoxicillin (80-90 mg/kg/day) given twice daily for respiratory infections to address increasing pneumococcal resistance 3.
For neonates and infants ≤3 months: maximum 30 mg/kg/day divided every 12 hours 1.
Key Dosing Considerations:
- Duration for uncomplicated CAP in children: 5 days is as effective as longer courses 2, 4. Studies demonstrate no significant difference in treatment failure between 3-day and 5-day courses for non-severe pneumonia, though 3-day regimens showed higher failure rates in some populations 4.
- A critical pitfall exists where larger/older children systematically receive inadequate mg/kg dosing because clinicians hesitate to exceed "adult maximum doses" 5. Children >60 kg often receive <40 mg/kg/day when they require 80-90 mg/kg/day for resistant organisms.
Renal Dosing Adjustment
Reduce dose in patients with severe renal impairment (GFR <30 mL/min) 1. The FDA label specifies this threshold, though specific adjusted doses require consultation of detailed prescribing information.
Contraindications
Absolute contraindication: History of serious hypersensitivity reactions (anaphylaxis or Stevens-Johnson syndrome) to amoxicillin or other beta-lactams (penicillins or cephalosporins) 1.
Warnings and Precautions
Critical Safety Concerns:
Anaphylactic reactions: Serious and occasionally fatal anaphylactic reactions occur with penicillin therapy. Discontinue immediately if a reaction occurs 1.
Severe cutaneous adverse reactions (SCAR): Monitor closely and discontinue if rash progresses 1.
Clostridioides difficile-associated diarrhea (CDAD): Ranges from mild diarrhea to fatal colitis. Evaluate if diarrhea develops during or after treatment 1.
Neurotoxicity risk in neonates: Concentrations >140 mg/L increase neurotoxicity risk. Regimens using 50-100 mg/kg doses show unacceptably high rates of potentially neurotoxic concentrations (24.9% and 84.5% respectively) 6.
Drug Interactions
- Probenecid: Coadministration not recommended 1
- Oral anticoagulants: May increase prothrombin time prolongation—monitor INR closely 1
- Allopurinol: Increases risk of rash 1
- Oral contraceptives: Amoxicillin may reduce efficacy—advise backup contraception 1
Monitoring Recommendations
Clinical Monitoring:
- Assess for hypersensitivity reactions, particularly during first doses
- Monitor for rash development and progression
- Evaluate for diarrhea suggesting CDAD
- In patients on anticoagulants: Monitor INR/prothrombin time
Treatment Response:
- For CAP in children: Clinical improvement should occur within 48-72 hours (afebrile, resolution of tachypnea, improved cough) 4
- Treatment failure indicators: Persistent fever >48 hours, worsening respiratory symptoms, or development of complications
Common Adverse Reactions
The most common adverse reactions (>1%) are diarrhea, rash, vomiting, and nausea 1.
Clinical Pitfalls to Avoid
Underdosing larger children: Do not cap doses at "adult maximum" when weight-based dosing (80-90 mg/kg/day) exceeds this—resistance patterns require adequate dosing 5.
Excessive duration: For uncomplicated pediatric CAP, 5 days is sufficient—longer courses (10 days) provide no additional benefit and increase adverse events 4.
Inappropriate spectrum expansion: Amoxicillin alone is inadequate when atypical pathogens (Mycoplasma, Chlamydia, Legionella) are suspected or in severe disease requiring hospitalization 2.
Neonatal dosing complexity: In neonates, adjust frequency based on postnatal age: twice daily for first 2 days, then three times daily from day 3 to optimize PK/PD while minimizing neurotoxicity 6.